Discontinued Operations - Sale of Infusionz to Bloomios (Details 1) - USD ($) |
12 Months Ended | |
|---|---|---|
Jun. 30, 2024 |
Jun. 30, 2023 |
|
| Operating expense | $ 35,287,018 | $ 33,300,703 |
| Discontinued Operations [Member] | ||
| Operating expense | 652,891 | |
| Management fees | 685,600 | |
| Advance for payroll | 50,000 | |
| Excess working capital | 388,565 | |
| Accrued interest | 247,885 | |
| Subtotal due from Bloomios | 2,024,941 | |
| Reserve | 1,179,498 | |
| Total amounts due from Bloomios | $ 845,443 | |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of expense for investment management fee, including, but not limited to, expense in connection with research, selection, supervision, and custody of investment. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|